Literature DB >> 10705195

Increased nitric oxide production in the spermatic vein of patients with varicocele.

E Ozbek1, Y Turkoz, R Gokdeniz, M Davarci, F Ozugurlu.   

Abstract

OBJECTIVE: To define the level of nitric oxide (NO) in the spermatic vein of patients with varicocele and its relation with male infertility.
MATERIALS AND METHODS: Following physical and color Doppler ultrasonographic examination, whole blood samples were drawn from a peripheral vein and a dilated varicocele vein from fourteen patients with clinically palpable varicocele (G2-3) before ligation. NO levels in the serum were determined as total nitrite by Greiss reaction and results were compared with Mann-Whitney U test.
RESULTS: NO levels in the internal spermatic vein were 36.05 +/- 8. 92 micromol/l, compared to 19.41 +/- 4.12 micromol/l in the peripheral vein and the difference was statistically significant (p < 0.01).
CONCLUSION: In view of our results, increased NO levels in the dilated varicocele vein might be responsible for spermatozoa dysfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705195     DOI: 10.1159/000020135

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  20 in total

1.  Current management of adolescent varicocele.

Authors:  D A Paduch; S J Skoog
Journal:  Rev Urol       Date:  2001

2.  Neuroprotective effect of etomidate in the central nervous system of streptozotocin-induced diabetic rats.

Authors:  Ozkan Ates; Neslihan Yucel; Suleyman R Cayli; Eyup Altinoz; Saim Yologlu; Ayhan Kocak; Celal Ozbek Cakir; Yusuf Turkoz
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

3.  Evaluation of the neuroprotective effects of citicoline after experimental spinal cord injury: improved behavioral and neuroanatomical recovery.

Authors:  Neslihan Yücel; Süleyman R Cayli; Ozkan Ateş; Neşe Karadağ; Serpil Firat; Yusuf Turköz
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

Review 4.  Treating varicocele in 2018: current knowledge and treatment options.

Authors:  M Zavattaro; C Ceruti; G Motta; S Allasia; L Marinelli; C Di Bisceglie; M P Tagliabue; M Sibona; L Rolle; F Lanfranco
Journal:  J Endocrinol Invest       Date:  2018-10-03       Impact factor: 4.256

5.  Neuroprotection by resveratrol against traumatic brain injury in rats.

Authors:  Ozkan Ates; Suleyman Cayli; Eyup Altinoz; Iclal Gurses; Neslihan Yucel; Metin Sener; Ayhan Kocak; Saim Yologlu
Journal:  Mol Cell Biochem       Date:  2006-08-19       Impact factor: 3.396

6.  The potential role of inducible nitric oxide synthase (iNOS) activity in the testicular dysfunction associated with varicocele: an experimental study.

Authors:  Ismail Türker Köksal; Tibet Erdoğru; Hakan Gülkesen; Cem Sezer; Mustafa Usta; Akif Ciftçioğlu; Mehmet Baykara
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

7.  Increased vasoconstrictor reactivity and decreased endothelial function in high grade varicocele; functional and morphological study.

Authors:  Oguzhan Yildiz; Husamettin Gul; Yaşar Ozgok; Onder Onguru; Mete Kilciler; Ahmet Aydin; Askin Isimer; A Cetin Harmankaya
Journal:  Urol Res       Date:  2003-07-11

8.  Testicular tissue nitric oxide and thiobarbituric acid reactive substance levels: evaluation with respect to the pathogenesis of varicocele.

Authors:  Uçler Kisa; M Murad Başar; Mehmet Ferhat; Erdal Yilmaz; Halil Başar; Osman Cağlayan; Ertan Batislam
Journal:  Urol Res       Date:  2004-02-10

9.  Neuroprotective effect of mexiletine in the central nervous system of diabetic rats.

Authors:  Ozkan Ates; Suleyman R Cayli; Eyup Altinoz; Neslihan Yucel; Ayhan Kocak; Ozcan Tarim; Akif Durak; Yusuf Turkoz; Saim Yologlu
Journal:  Mol Cell Biochem       Date:  2006-03-16       Impact factor: 3.396

10.  Melatonin ameliorates cerebral vasospasm after experimental subarachnoidal haemorrhage correcting imbalance of nitric oxide levels in rats.

Authors:  M A Aladag; Y Turkoz; H Parlakpinar; H Ozen; M Egri; S C Unal
Journal:  Neurochem Res       Date:  2009-05-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.